| AEREA Y POSTAL EX-IAAC | 2025 | 0.058 | KG | FLUCONAZOL COMP RELACIONADO B (USP), USP, S/M FLUCONAZOL COMP RELACIONADO B (USP) Estandares primarios para analisis en laboratorio | UNITED STATES | UNITED STATES | 829.37 |
| AEREA Y POSTAL EX-IAAC | 2025 | 21.4 | KG | 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-, S/M, S/M 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS | CHINA | SWITZERLAND | 4534 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.014 | KG | Meloxicam impureza D (EP), S/M, S/M Meloxicam impurity D CRS PRESENTACION: 1 VIAL = 20 MG, CODIGO: 202400416, LOTE: L04.00 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO Meloxicam impureza D (EP), S/M, S/M | FRANCE | FRANCE | 81.84 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.014 | KG | Meloxicam impureza B (EP), S/M, S/M Meloxicam impurity B CRS PRESENTACION: 1 VIAL = 5 MG, CODIGO: 202400414, LOTE: L03.00 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO Meloxicam impureza B (EP), S/M, S/M | FRANCE | FRANCE | 81.84 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.071 | KG | ZIPRASIDONA COMPUESTO RELACIONADO F (USP), USP, S/M ZIPRASIDONE RELATED COMPOUND F (15 MG) (SODIUM 2-(2-AMINO-5-(2-[4-(BENZO[D]ISOTHIAZOI-3- ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1 VIAL X 15 MG, 1724474,LOTE:R137A0 | UNITED STATES | UNITED STATES | 799.37 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.3 | KG | 9-B-D-RIBOFURANOSYLADENINE, S/M, S/M 9-B-D-RIBOFURANOSYLADENINE MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 148.25 |
| AEREA Y POSTAL EX-IAAC | 2025 | 10 | KG | 1-[17ß-ACETOXY-3 a -hydroxy-2ß-(morpholin-4yl)-5 a-androstan-16ß-yl]-1-(prop-2-enyl)pyrrol 1-[17ß-ACETOXY-3 a -hydroxy-2ß-(morpholin-4yl)-5 a-androstan-16ß-yl]-1-(prop-2-enyl)pyrrol COMERCIALIZADO EN KG MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS | CHINA | CHINA | 63687.1 |
| AEREA Y POSTAL EX-IAAC | 2025 | 20 | KG | 5-METHYL-N-[4-(TRIFLUOROMETYL)-PHENYL]-4- SIOXAZOLECARBOXAMIDE MICRO, S/M, S/M 5-METHYL-N-[4-(TRIFLUOROMETYL)-PHENYL]-4- SIOXAZOLECARBOXAMIDE MICRO MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | SPAIN | 10271 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.223 | KG | RISPERIDONA IMPUREZA ESTANDAR (BP), BP, S/M RISPERIDONA IMPUREZA ESTANDAR (BP) ESTANDAR PARA ANALISIS EN LABORATORIO | UNITED KINGDOM | UNITED KINGDOM | 137.7 |
| AEREA Y POSTAL EX-IAAC | 2025 | 50 | KG | 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tethahydro-2-methyl- 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tethahydro-2-methyl- MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | INDIA | INDIA | 25014.4 |
| AEREA Y POSTAL EX-IAAC | 2025 | 50 | KG | Piperazine,1-acecyl-4-[4-[[2-[2.,4- diclorophenyl)2-(1.Himidazol-1-ylmenthyl)-1.3-dioxolan KETOCONAZOLE USP (MICRONISED) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 3158.3 |
| MARITIMA DEL CALLAO | 2025 | 400 | KG | 2-(2-(4-DIBENZO[B][1,4] BENZOTHIAZEPINE-6-YL-PIPERAZIN-1-YL) ETHOXY)ETHANOL; (E)- BUT-2-EN 2-(2-(4-DIBENZO[B][1,4] BENZOTHIAZEPINE-6-YL-PIPERAZIN-1-YL) ETHOXY)ETHANOL; (E)- BUT-2-EN MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 18931.9 |